Matinas BioPharma Holdings Inc
For the period ended Mar 3, 2025. Filed Mar 3, 2025.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
Mar 3, 2025 · Filed Mar 3, 2025
Use the contents to explore the available documents and sections.
Contents
PROXY STATEMENT
This proxy statement contains information related to a Special Meeting of Stockholders to be held on April 4, 2025 at 9 a.m. local time via the internet at www.virtualshareholdermeeting.com/MTNB2025SM, or at such other time and place to which the Special Meeting may be adjourned or postponed. The enclosed proxy is solicited by the Board of Directors of Matinas BioPharma Holdings, Inc. (the “Board”). The proxy materials relating to the Special Meeting are being mailed to stockholders entitled to vote at the meeting on or about March 3, 2025.
Important Notice of Availability of Proxy Materials for the Special Meeting of Stockholders to be held on April 4, 2025.
Our proxy materials including our Proxy Statement for the Special Meeting and proxy card are available on the Internet at www.proxyvote.com.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.